Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences

Journal of the American College of Cardiology

Volumn 69, Issue 7, 2017, Pages 841-858

  Javaheri, Shahrokh ^a   Barbe, Ferran ^b   Campos Rodriguez, Francisco ^c   Dempsey, Jerome A ^d   Khayat, Rami ^e   Javaheri, Sogol ^f   Malhotra, Atul ^g   Martinez Garcia, Miguel A ^h   Mehra, Reena ⁱ   Pack, Allan I ^j   Polotsky, Vsevolod Y ^k   Redline, Susan ^f,l   Somers, Virend K ^m  

^a Bethesda North Hospital   (United States)

^b HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^c HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

ⁱ CASE WESTERN RESERVE UNIVERSITY   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^m MAYO CLINIC   (United States)

more..

Author keywords

central sleep apnea; hypertension; obstructive sleep apnea

Indexed keywords

OXYGEN;

ACUTE HEART FAILURE; ADRENERGIC STIMULATION; ASYMPTOMATIC DISEASE; CARDIOPULMONARY FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COMORBIDITY; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HEART ARRHYTHMIA; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HOSPITAL READMISSION; HUMAN; HYPERTENSION; INCIDENCE; INTERMITTENT HYPOXIA; ISCHEMIC HEART DISEASE; KINESIOTHERAPY; METABOLIC DISORDER; MOLECULAR PATHOLOGY; NERVE STIMULATION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PHRENIC NERVE; POSITIVE END EXPIRATORY PRESSURE; PREHYPERTENSION; PREVALENCE; REVIEW; SLEEP DISORDERED BREATHING; SUDDEN DEATH; SYMPATHETIC TONE; THERAPY EFFECT; TRANSIENT ISCHEMIC ATTACK; VASCULAR ENDOTHELIUM; WEIGHT REDUCTION; CARDIOVASCULAR DISEASES; COMPLICATION; SLEEP APNEA SYNDROMES;

CARDIOVASCULAR DISEASES; HUMANS; SLEEP APNEA SYNDROMES;

EID: 85012952342     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.11.069     Document Type: Review

References (113)

1. 1 Mozaffarian, D., Benjamin, E.J., Go, A.S., et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
2. 2 Peppard, P.E., Young, T., Barnet, J.H., et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177 (2013), 1006–1014.
3. 3 Javaheri, S., Drager, L.F., Lorenzi-Filho, G., Sleep and cardiovascular disease: present and future. Kryger, M.H., Roth, T., Dement, W.C., (eds.) Principles and Practices of Sleep Medicine, 6th edition, 2017, Elsevier, Philadelphia, PA, 1222–1228.
4. 4 Javaheri, S., Dempsey, J.A., Central sleep apnea. Compr Physiol 3 (2013), 141–163.
5. 5 Lyons, O.D., Bradley, T.D., Heart failure and sleep apnea. Can J Cardiol 31 (2015), 898–908.
6. 6 May, A.M., Blackwell, T., Stone, P.H., et al., for the MrOS Sleep (Outcomes of Sleep Disorders in Older Men) Study Group. Central sleep-disordered breathing predicts incident atrial fibrillation in older men. Am J Respir Crit Care Med 193 (2016), 783–791.
7. 7 Javaheri, S., Blackwell, T., Ancoli-Israel, S., et al., for the Osteoporotic Fractures in Men Study Research Group. Sleep-disordered breathing and incident heart failure in older men. Am J Respir Crit Care Med 193 (2016), 561–568.
8. 8 Javaheri, S., Cardiovascular Diseases. Kryger, M.H., Avidan, A.Y., Berry, R.B., (eds.) Atlas of Clinical Sleep Medicine, 2nd edition, 2014, Saunders, Philadelphia, PA, 316–328.
9. 9 Dempsey, J.A., Veasey, S.C., Morgan, B.J., et al. Pathophysiology of sleep apnea. Physiol Rev 90 (2010), 47–112.
10. 10 Jordan, A.S., McSharry, D.G., Malhotra, A., Adult obstructive sleep apnoea. Lancet 383 (2014), 736–747.
11. 11 Mendelson, M., Lyons, O.D., Yadollahi, A., et al. Effects of exercise training on sleep apnoea in patients with coronary artery disease: a randomised trial. Eur Respir J 48 (2016), 142–150.
12. 12 Somers, V., Javaheri, S., Cardiovascular effects of sleep-related breathing disorders. Kryger, M.H., Roth, T., Dement, W.C., (eds.) Principles and Practices of Sleep Medicine, 6th edition, 2017, Elsevier, Philadelphia, PA, 1243–1252.
13. 13 Bauters, F., Rietzschel, E.R., Hertegonne, K.B., et al. The link between obstructive sleep apnea and cardiovascular disease. Curr Atheroscler Rep, 18, 2016, 1.
14. 14 Baltzis, D., Bakker, J.P., Patel, S.R., et al. Obstructive sleep apnea and vascular diseases. Compr Physiol 6 (2016), 1519–1528.
15. 15 De Luca Canto, G., Pachêco-Pereira, C., Aydinoz, S., et al. Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 11 (2015), 27–36.
16. 16 Pak, V.M., Keenan, B.T., Jackson, N., et al. Adhesion molecule increases in sleep apnea: beneficial effect of positive airway pressure and moderation by obesity. Int J Obes (Lond) 39 (2015), 472–479.
17. 17 Baessler, A., Nadeem, R., Harvey, M., et al. Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers—a meta-analysis. J Inflamm (Lond), 10, 2013, 13.
18. 18 Kohler, M., Stoewhas, A.C., Ayers, L., et al. Effects of continuous positive airway plressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 184 (2011), 1192–1199.
19. 19 Chirinos, J.A., Gurubhagavatula, I., Teff, K., et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 370 (2014), 2265–2275.
20. 20 Drager, L.F., Polotsky, V.Y., O'Donnell, C.P., et al. Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. Am J Physiol Heart Circ Physiol 309 (2015), H1101–H1111.
21. 21 Pamidi, S., Wroblewski, K., Stepien, M., et al. Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial. Am J Respir Crit Care Med 192 (2015), 96–105.
22. 22 Weinstock, T.G., Wang, X., Rueschman, M., et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep 35 (2012), 617–625B.
23. 23 Salord, N., Fortuna, A.M., Monasterio, C., et al. A randomized controlled trial of continuous positive airway pressure on glucose tolerance in obese patients with obstructive sleep apnea. Sleep 39 (2016), 35–41.
24. 24 Pamidi, S., Tasali, E., Continuous positive airway pressure for improving glycemic control in type 2 diabetes: where do we stand?. Am J Respir Crit Care Med 194 (2016), 397–399.
25. 25 Bratton, D.J., Stradling, J.R., Barbé, F., et al. Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials. Thorax 69 (2014), 1128–1135.
26. 26 Bakker, J.P., Edwards, B.A., Gautam, S.P., et al. Blood pressure improvement with continuous positive airway pressure is independent of obstructive sleep apnea severity. J Clin Sleep Med 10 (2014), 365–369.
27. 27 Alajmi, M., Mulgrew, A.T., Fox, J., et al. Impact of continuous positive airway pressure. therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 185 (2007), 67–72.
28. 28 Fava, C., Dorigoni, S., Dalle Vedove, F., et al. Effect of CPAP on blood pressure in patients with OSA/hypopnea: a systematic review and meta-analysis. Chest 145 (2014), 762–771.
29. 29 Montesi, S.B., Edwards, B.A., Malhotra, A., et al. The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med 8 (2012), 587–596.
30. 30 Bazzano, L.A., Khan, Z., Reynolds, K., et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50 (2007), 417–423.
31. 31 Haentjens, P., Van Meerhaeghe, A., Moscariello, A., et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167 (2007), 757–764.
32. 32 Mo, L., He, Q.Y., [Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta-analysis of clinical trials]. Zhonghua Yi Xue Za Zhi 87 (2007), 1177–1180.
33. 33 Liu, L., Cao, Q., Guo, Z., et al. Continuous positive airway pressure in patients with obstructive sleep apnea and resistant hypertension: a meta-analysis of randomized controlled trials. J Clin Hypertens (Greenwich) 18 (2016), 153–158.
34. 34 Muxfeldt, E.S., Margallo, V., Costa, L.M., et al. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension 65 (2015), 736–742.
35. 35 Iftikhar, I.H., Valentine, C.W., Bittencourt, L.R., et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens 32 (2014), 2341–2350 discussion 2350.
36. 36 de Oliveira, A.C., Martinez, D., Massierer, D., et al. The antihypertensive effect of positive airway pressure on resistant hypertension of patients with obstructive sleep apnea: a randomized, double-blind, clinical trial. Am J Respir Crit Care Med 190 (2014), 345–347.
37. 37 Martínez-García, M.A., Capote, F., Campos-Rodríguez, F., et al., for the Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: The HIPARCO randomized clinical trial. JAMA 310 (2013), 2407–2415.
38. 38 Pedrosa, R.P., Drager, L.F., de Paula, L.K., et al. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest 144 (2013), 1487–1494.
39. 39 Lozano, L., Tovar, J.L., Sampol, G., et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 28 (2010), 2161–2168.
40. 40 Sánchez-de-la-Torre, M., Khalyfa, A., Sánchez-de-la-Torre, A., et al., for the Spanish Sleep Network. Precision medicine in patients with resistant hypertension and obstructive sleep apnea: blood pressure response to continuous positive airway pressure treatment. J Am Coll Cardiol 66 (2015), 1023–1032.
41. 41 Thunström, E., Manhem, K., Rosengren, A., et al. Blood pressure response to losartan and continuous positive airway pressure in hypertension and obstructive sleep apnea. Am J Respir Crit Care Med 193 (2016), 310–320.
42. 42 Javaheri, S., Javaheri, S., Javaheri, A., Sleep apnea, heart failure and pulmonary hypertension. Curr Heart Fail Rep 10 (2013), 315–320.
43. 43 Nieto, F.J., Young, T., Peppard, P.E., et al. Systemic and pulmonary hypertension in obstructive sleep apnea. Kryger, M.H., Roth, T., Dement, W.C., (eds.) Principles and Practices of Sleep Medicine, 6th edition, 2017, Elsevier, Philadelphia, PA, 1253–1263.
44. 44 Arias, M.A., García-Río, F., Alonso-Fernández, A., et al. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 27 (2006), 1106–1113.
45. 45 McLaughlin, V.V., Archer, S.L., Badesch, D.B., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association. J Am Coll Cardiol 53 (2009), 1573–1619.
46. 46 Lyons, O.W., Ryan, C.M., Sleep apnea and stroke. Can J Cardiol 31 (2015), 918–927.
47. 47 Parra, O., Sánchez-Armengol, Á., Capote, F., et al. Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea: a randomized controlled trial. J Sleep Res 24 (2015), 47–53.
48. 48 Kim, Y., Koo, Y.S., Lee, H.Y., et al. Can continuous positive airway pressure reduce the risk of stroke in obstructive sleep apnea patients? A systematic review and meta-analysis. PLoS One, 11, 2016, e0146317.
49. 49 McEvoy, R.D., Antic, N.A., Heeley, E., et al., for the SAVE Investigators and Coordinators. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375 (2016), 919–931.
50. 50 Kernan, W.N., Ovbiagele, B., Black, H.R., et al. for the American Heart Association Stroke Council Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45 (2014), 2160–2236.
51. 51 Craig, S., Pepperell, J.C., Kohler, M., et al. Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial. J Sleep Res 18 (2009), 329–336.
52. 52 Ryan, C.M., Usui, K., Floras, J.S., et al. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60 (2005), 781–785.
53. 53 Fein, A.S., Shvilkin, A., Shah, D., et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 62 (2013), 300–305.
54. 54 Neilan, T.G., Farhad, H., Dodson, J.A., et al. Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc, 2, 2013, e000421.
55. 55 Naruse, Y., Tada, H., Satoh, M., et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm 10 (2013), 331–337.
56. 56 Holmqvist, F., Guan, N., Zhu, Z., et al., for the ORBIT-AF Investigators. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Am Heart J 169 (2015), 647–654.e2.
57. 57 Qureshi, W.T., Nasir, U.B., Alqalyoobi, S., et al. Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea. Am J Cardiol 116 (2015), 1767–1773.
58. 58 Calkins, H., Kuck, K.H., Cappato, R., et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 9 (2012), 632–696.e21.
59. 59 Peker, Y., Franklin, K.A., Hedner, J., Coronary artery disease and obstructive sleep apnea. Kryger, M.H., Roth, T., Dement, W.C., (eds.) Principles and Practices of Sleep Medicine, 6th edition, 2017, Elsevier, Philadelphia, PA, 1264–1270.
60. 60 Wu, X., Lv, S., Yu, X., et al. Treatment of OSA reduces the risk of repeat revascularization after percutaneous coronary intervention. Chest 147 (2015), 708–718.
61. 61 Marin, J.M., Carrizo, S.J., Vicente, E., et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005), 1046–1053.
62. 62 Campos-Rodriguez, F., Martinez-Garcia, M.A., de la Cruz-Moron, I., et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 156 (2012), 115–122.
63. 63 Barbé, F., Durán-Cantolla, J., Sánchez-de-la-Torre, M., et al., for the Spanish Sleep and Breathing Network. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 307 (2012), 2161–2168.
64. 64 Peker, Y., Glantz, H., Eulenburg, C., et al. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea: the RICCADSA randomized controlled trial. Am J Respir Crit Care Med 194 (2016), 613–620.
65. 65 Esquinas, C., Sánchez-de-la Torre, M., Aldomá, A., et al., for the Spanish Sleep Network. Rationale and methodology of the impact of continuous positive airway pressure on patients with ACS and nonsleepy OSA: the ISAACC trial. Clin Cardiol 36 (2013), 495–501.
66. 66 Kuniyoshi, F.H., Garcia-Touchard, A., Gami, A.S., et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 52 (2008), 343–346.
67. 67 Gami, A.S., Olson, E.J., Shen, W.K., et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 62 (2013), 610–616.
68. 68 Gami, A.S., Howard, D.E., Olson, E.J., et al. Day-night pattern of sudden cardiac death in obstructive sleep apnea. N Engl J Med 352 (2005), 1206–1214.
69. 69 Iftikhar, I.H., Kline, C.E., Youngstedt, S.D., Effects of exercise training on sleep apnea: a meta-analysis. Lung 192 (2014), 175–184.
70. 70 Redolfi, S., Bettinzoli, M., Venturoli, N., et al. Attenuation of obstructive sleep apnea and overnight rostral fluid shift by physical activity. Am J Respir Crit Care Med 191 (2015), 856–858.
71. 71 Camacho, M., Certal, V., Abdullatif, J., et al. Myofunctional therapy to treat obstructive sleep apnea: a systematic review and meta-analysis. Sleep 38 (2015), 669–675.
72. 72 Tachikawa, R., Ikeda, K., Minami, T., et al. Changes in energy metabolism after continuous positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 194 (2016), 729–738.
73. 73 Javaheri, S., Heart failure. Kryger, M.H., Roth, T., Dement, W.C., (eds.) Principles and Practices of Sleep Medicine, 6th edition, 2017, Elsevier, Philadelphia, PA, 1271–1285.
74. 74 Lanfranchi, P.A., Somers, V.K., Braghiroli, A., et al. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 107 (2003), 727–732.
75. 75 Wachter, R., Lüthje, L., Klemmstein, D., et al. Impact of obstructive sleep apnoea on diastolic function. Eur Respir J 41 (2013), 376–383.
76. 76 Gottlieb, D.J., Yenokyan, G., Newman, A.B., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: The Sleep Heart Health Study. Circulation 122 (2010), 352–360.
77. 77 Roca, G.Q., Redline, S., Claggett, B., et al. Sex-specific association of sleep apnea severity with subclinical myocardial injury, ventricular hypertrophy, and heart failure risk in a community-dwelling cohort: The Atherosclerosis Risk in Communities–Sleep Heart Health Study. Circulation 132 (2015), 1329–1337.
78. 78 Oldenburg, O., Wellmann, B., Buchholz, A., et al. Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients. Eur Heart J 37 (2016), 1695–1703.
79. 79 Bitter, T., Faber, L., Hering, D., et al. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail 11 (2009), 602–608.
80. 80 Herrscher, T.E., Akre, H., Øverland, B., et al. High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail 17 (2011), 420–425.
81. 81 Khayat, R., Jarjoura, D., Porter, K., et al. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur Heart J 36 (2015), 1463–1469.
82. 82 Chenuel, B.J., Smith, C.A., Skatrud, J.B., et al. Increased propensity for apnea in response to acute elevations in left atrial pressure during sleep in the dog. J Appl Physiol (1985) 101 (2006), 76–83.
83. 83 Gandhi, P.U., Szymonifka, J., Motiwala, S.R., et al. Characterization and prediction of adverse events from intensive chronic heart failure management and effect on quality of life: results from the Pro-B-Type Natriuretic Peptide Outpatient-Tailored Chronic Heart Failure Therapy (PROTECT) study. J Card Fail 21 (2015), 9–15.
84. 84 Lamba, J., Simpson, C.S., Redfearn, D.P., et al. Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace 13 (2011), 1174–1179.
85. 85 Ueno, L.M., Drager, L.F., Rodrigues, A.C., et al. Effects of exercise training in patients with chronic heart failure and sleep apnea. Sleep 32 (2009), 637–647.
86. 86 Javaheri, S., Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 101 (2000), 392–397.
87. 87 Usui, K., Bradley, T.D., Spaak, J., et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 45 (2005), 2008–2011.
88. 88 Hall, A.B., Ziadi, M.C., Leech, J.A., et al. Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: a randomized study. Circulation 130 (2014), 892–901.
89. 89 Kaneko, Y., Floras, J.S., Usui, K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348 (2003), 1233–1241.
90. 90 Mansfield, D.R., Gollogly, C., Kaye, D.M., Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169 (2004), 361–366.
91. 91 Javaheri, S., Brown, L.K., Randerath, W.J., Positive airway pressure therapy with adaptive servo-ventilation: part 2. Chest 146 (2014), 858–868.
92. 92 Javaheri, S., Caref, E.B., Chen, E., et al. Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med 183 (2011), 539–546.
93. 93 Arias, M.A., García-Río, F., Alonso-Fernández, A., et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112 (2005), 375–383.
94. 94 Artz, M., Floras, J.S., Logan, A.G., et al., for the CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115 (2007), 3173–3180.
95. 95 Javaheri, S., Abraham, W.T., Brown, C., et al. Prevalence of obstructive sleep apnea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J 25 (2004), 260–266.
96. 96 Costanzo, M.R., Khayat, R., Ponikowski, P., et al. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol 65 (2015), 72–84.
97. 97 Naughton, M.T., Benard, D.C., Liu, P.P., et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152 (1995), 473–479.
98. 98 van de Borne, P., Oren, R., Abouassaly, C., et al. Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 81 (1998), 432–436.
99. 99 Andreas, S., Bingeli, C., Mohacsi, P., et al. Nasal oxygen and muscle sympathetic nerve activity in heart failure. Chest 123 (2003), 366–371.
100. 100 Naughton, M.T., Benard, D.C., Rutherford, R., et al. Effect of continuous positive airway pressure on central sleep apnea and nocturnal PCO2 in heart failure. Am J Respir Crit Care Med 150 (1994), 1598–1604.
101. 101 Granton, J.T., Naughton, M.T., Benard, D.C., et al. CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 153 (1996), 277–282.
102. 102 Pepperell, J.C., Maskell, N.A., Jones, D.R., et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 168 (2003), 1109–1114.
103. 103 Staniforth, A.D., Kinnear, W.J., Starling, R., et al. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 19 (1998), 922–928.
104. 104 Naughton, M.T., Cheyne-stokes respiration: friend or foe?. Thorax 67 (2012), 357–360.
105. 105 Cowie, M.R., Woehrle, H., Wegscheider, K., et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med 373 (2015), 1095–1105.
106. 106 Javaheri, S., Brown, L.K., Randerath, W.J., Positive airway pressure therapy with adaptive servoventilation: part 1: operational algorithms. Chest 146 (2014), 514–523.
107. 107 Javaheri, S., Brown, L.K., Randerath, W., et al. SERVE-HF: more questions than answers. Chest 149 (2016), 900–904.
108. 108 Javaheri, S., Pembrey's dream: the time has come for a long-term trial of nocturnal supplemental nasal oxygen to treat central sleep apnea in congestive heart failure. Chest 123 (2003), 322–325.
109. 109 Bodez, D., Guellich, A., Kharoubi, M., et al. Prevalence, severity, and prognostic value of sleep apnea syndromes in cardiac amyloidosis. Sleep 39 (2016), 1333–1341.
110. 110 Haque, W.A., Boehmer, J., Clemson, B.S., et al. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 27 (1996), 353–357.
111. 111 Ponikowski, P., Javaheri, S., Michalkiewicz, D., et al. Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure. Eur Heart J 33 (2012), 889–894.
112. 112 Costanzo, M.R., Ponikowski, P., Javaheri, S., et al., for the remedé System Pivotal Trial Study Group. Randomised controlled trial of transvenous neurostimulation for central sleep apnoea. Lancet 388 (2016), 974–982.
113. 113 Mokhlesi, B., Finn, L.A., Hagen, E.W., et al. Obstructive sleep apnea during REM sleep and hypertension. Results of the Wisconsin Sleep Cohort. Am J Respir Crit Care Med 190 (2014), 1158–1167.